Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07136610 · ClinicalTrials.gov registry record · NA
Standardized Application of Feeding Evaluations Using SMART Tool
A NA study of Infant and Young Child Feeding, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 3,500
- Enrollment target
- 14
- Study locations
NCT07136610: Recruiting NA study of Infant and Young Child Feeding, sponsored by Wake Forest University Health Sciences.
NCT07136610 is a NA study of Infant and Young Child Feeding that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 3,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher). The trial reports 14 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07136610, a NA study of Infant and Young Child Feeding, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,500 participants
- Enrollment target
- 14
- Study locations
Study Summary
Premature and medically complex infants have delayed development of oral feeding skills, leading to prolonged hospitalization, costs, and family stress. There is no "gold standard" infant feeding skill assessment tool for bedside clinicians. The research team developed a novel feeding skill assessment, the SMART Tool, to monitor infant feeding skill development in the neonatal intensive care unit. This study aims to determine whether this tool improves clinical outcomes, including reduced hospital days and enhanced safety and quality of infant feedings.
Primary Outcome
Days from birth to discharge
Conditions Studied
Interventions
- BEHAVIORAL SMART Tool
Study Locations (14)
Wisconsin
- Aurora Medical Center Grafton - Grafton
- Aurora BayCare Medical Center - Green Bay
- Aurora Medical Center Kenosha - Kenosha
- Aurora Sinai Medical Center - Milwaukee
- Aurora Medical Center Oshkosh - Oshkosh
- Aurora Medical Center - Sheboygan County - Sheboygan
- Aurora Medical Center - Summit - Summit
- Aurora West Allis Medical Center - West Allis
Illinois
- Advocate Good Shepherd Hospital - Barrington
- Advocate Trinity Hospital - Chicago
- Advocate Sherman Hospital - Elgin
- Advocate Condell Medical Center - Libertyville
- Advocate Christ Medical Center (Advocate Children's Hospital - Oak Lawn) - Oak Lawn
- Advocate Lutheran General Hospital (Advocate Children's Hospital - Park Ridge) - Park Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT07136610 shows while recruiting
NCT07136610 is an interventional study that assigns participants to a tested intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher).
The record links to 1 condition, with Infant and Young Child Feeding appearing as the primary indexed condition, and to 1 intervention - of which SMART Tool is the first listed.
NCT07136610 lists 14 locations in 2 states (Wisconsin, Illinois).
Frequently Asked Questions
What is clinical trial NCT07136610 about?
NCT07136610 is a clinical study titled "Standardized Application of Feeding Evaluations Using SMART Tool". Premature and medically complex infants have delayed development of oral feeding skills, leading to prolonged hospitalization, costs, and family stress. There is no "gold standard" infant feeding skill assessment tool for bedside clinicians. The research team developed a novel feeding skill assessme...
What is the current status of trial NCT07136610?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,500 participants. The study started on 2025-08-01. Estimated completion is 2026-07.
What conditions does trial NCT07136610 study?
This clinical trial studies the following conditions: Infant and Young Child Feeding.
What interventions are being tested in trial NCT07136610?
The interventions under investigation include: SMART Tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT07136610?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07136610 being conducted?
This trial has 14 study locations across Illinois, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07136610's enrollment target sits among peer trials
3,500 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI